Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yvonne W S Jauw"'
Autor:
Yvonne W S Jauw, Josée M Zijlstra, Daphne de Jong, Danielle J Vugts, Sonja Zweegman, Otto S Hoekstra, Guus A M S van Dongen, Marc C Huisman
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169828 (2017)
Treatment of patients with diffuse large B cell lymphoma (DLBCL) includes rituximab, an anti-CD20 monoclonal antibody (mAb). Insufficient tumor targeting might cause therapy failure. Tumor uptake of 89Zirconium (89Zr)-mAb is a potential imaging bioma
Externí odkaz:
https://doaj.org/article/aa08a95257eb45329d6e3009ae7b3c4c
Autor:
Jessica E. Wijngaarden, Yvonne W. S. Jauw, Gerben J. C. Zwezerijnen, Berlinda J. de Wit-van der Veen, Daniëlle J. Vugts, Josée M. Zijlstra, Guus A. M. S. van Dongen, Ronald Boellaard, C. Willemien Menke-van der Houven van Oordt, Marc C. Huisman
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Background Distribution of mAbs into tumour tissue may occur via different processes contributing differently to the 89Zr-mAb uptake on PET. Target-specific binding in tumours is of main interest; however, non-specific irreversible uptake ma
Externí odkaz:
https://doaj.org/article/e2826c2a0dcd4ad8b44c5b0685c08e6a
Autor:
Jessica E. Wijngaarden, Marc C. Huisman, Johanna E. E. Pouw, C. Willemien Menke-van der Houven van Oordt, Yvonne W. S. Jauw, Ronald Boellaard
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Purpose Zirconium-89-immuno-positron emission tomography (89Zr-immuno-PET) has enabled visualization of zirconium-89 labelled monoclonal antibody (89Zr-mAb) uptake in organs and tumors in vivo. Patlak linearization of 89Zr-immuno-PET quantif
Externí odkaz:
https://doaj.org/article/f7e591d6ed574f1a8604194122efd863
Autor:
Marc C. Huisman, C. Willemien Menke-van der Houven van Oordt, Josée M. Zijlstra, Otto S. Hoekstra, Ronald Boellaard, Guus A. M. S. van Dongen, Dhaval K. Shah, Yvonne W. S. Jauw
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Background 89Zirconium-immuno-positron emission tomography (89Zr-immuno-PET) is used for assessment of target status to guide antibody-based therapy. We aim to determine the relation between antibody tumor uptake and target concentration to
Externí odkaz:
https://doaj.org/article/7ca500900e7d40a997a3ff94b199da2c
Autor:
Esther E. E. Drees, Yvonne W. S. Jauw, Erik van Dijk, Sven Borchmann, Sandra A. W. M. Verkuijlen, Phylicia Stathi, Nils J. Groenewegen, Nathalie J. Hijmering, Daniella R. A. I. Berry, Eric J. Meershoek, Danielle Hoogmoed, Anne Kwakman, Tessa J. Molenaar, Dirk M. Pegtel, Bauke Ylstra, Daphne de Jong, Josée M. Zijlstra, Margaretha G. M. Roemer
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e749 (2022)
Externí odkaz:
https://doaj.org/article/26363f9c16cc417598430c0d786f8904
Autor:
Bart M. de Vries, Sandeep S. V. Golla, Gerben J. C. Zwezerijnen, Otto S. Hoekstra, Yvonne W. S. Jauw, Marc C. Huisman, Guus A. M. S. van Dongen, Willemien C. Menke-van der Houven van Oordt, Josée J. M. Zijlstra-Baalbergen, Liesbet Mesotten, Ronald Boellaard, Maqsood Yaqub
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 596 (2022)
Acquisition time and injected activity of 18F-fluorodeoxyglucose (18F-FDG) PET should ideally be reduced. However, this decreases the signal-to-noise ratio (SNR), which impairs the diagnostic value of these PET scans. In addition, 89Zr-antibody PET i
Externí odkaz:
https://doaj.org/article/a126295b2b554a6f80b62a95d68b22e0
Autor:
Ananthi Somasundaram, David Vállez García, Elisabeth Pfaehler, Yvonne W. S. Jauw, Josée M. Zijlstra, Guus A. M. S. van Dongen, Willemien C. Menke-van der Houven van Oordt, Marc C. Huisman, Elisabeth G. E. de Vries, Ronald Boellaard
Publikováno v:
EJNMMI PHYSICS, 9(1):16. Springer International Publishing AG
Somasundaram, A, Vállez García, D, Pfaehler, E, Jauw, Y W S, Zijlstra, J M, van Dongen, G A M S, Menke-van der Houven van Oordt, W C, Huisman, M C, de Vries, E G E & Boellaard, R 2022, ' Noise sensitivity of Zr-89-Immuno-PET radiomics based on count-reduced clinical images ', EJNMMI PHYSICS, vol. 9, no. 1, 16, pp. 16 . https://doi.org/10.1186/s40658-022-00444-4
EJNMMI physics, 9(1):16. SpringerOpen
EJNMMI PHYSICS, 9(1). Springer International Publishing AG
Somasundaram, A, Vállez García, D, Pfaehler, E, Jauw, Y W S, Zijlstra, J M, van Dongen, G A M S, Menke-van der Houven van Oordt, W C, Huisman, M C, de Vries, E G E & Boellaard, R 2022, ' Noise sensitivity of Zr-89-Immuno-PET radiomics based on count-reduced clinical images ', EJNMMI PHYSICS, vol. 9, no. 1, 16, pp. 16 . https://doi.org/10.1186/s40658-022-00444-4
EJNMMI physics, 9(1):16. SpringerOpen
EJNMMI PHYSICS, 9(1). Springer International Publishing AG
Purpose Low photon count in 89Zr-Immuno-PET results in images with a low signal-to-noise ratio (SNR). Since PET radiomics are sensitive to noise, this study focuses on the impact of noise on radiomic features from 89Zr-Immuno-PET clinical images. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe2083a6ec112dfe0927dbdb82f94a4
https://research.vumc.nl/en/publications/035214d0-d658-452d-a0f1-281ec67aaeb3
https://research.vumc.nl/en/publications/035214d0-d658-452d-a0f1-281ec67aaeb3
Autor:
Dhaval K. Shah, C. Willemien Menke-van der Houven van Oordt, Otto S. Hoekstra, Josée M. Zijlstra, Marc C. Huisman, Ronald Boellaard, Yvonne W. S. Jauw, Guus A.M.S. van Dongen
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-7 (2021)
EJNMMI Research
EJNMMI Research, 11(1). Springer Berlin
EJNMMI Research
EJNMMI Research, 11(1). Springer Berlin
Background 89Zirconium-immuno-positron emission tomography (89Zr-immuno-PET) is used for assessment of target status to guide antibody-based therapy. We aim to determine the relation between antibody tumor uptake and target concentration to improve f
Autor:
Ananthi, Somasundaram, David Vállez, García, Elisabeth, Pfaehler, Yvonne W S, Jauw, Josée M, Zijlstra, Guus A M S, van Dongen, Willemien C, Menke-van der Houven van Oordt, Marc C, Huisman, Elisabeth G E, de Vries, Ronald, Boellaard
Publikováno v:
EJNMMI physics. 9(1)
Low photon count inCount-splitFor S50p, a total of 92% and 90% features were classified as having good or excellent ICC and SDM respectively, while for S25p, these decreased to 81% and 31%. In total, 148 features (31%) showed robustness to noise with
Autor:
Marc C. Huisman, Sonja Zweegman, Josée M. Zijlstra, Henrica C.W. de Vet, Yvonne W. S. Jauw, Ronald Boellaard, Guus A.M.S. van Dongen, Adrienne H. Brouwers, Carolien P. Schröder, Simone Pieplenbosch, Elisabeth G.E. de Vries, Frederike Bensch, C. Willemien Menke-van der Houven van Oordt, Otto S. Hoekstra
Publikováno v:
Jauw, Y W S, Bensch, F, Brouwers, A H, Hoekstra, O S, Zijlstra, J M, Pieplenbosch, S, Schröder, C P, Zweegman, S, van Dongen, G A M S, Menke-van der Houven van Oordt, C W, de Vries, E G E, de Vet, H C W, Boellaard, R & Huisman, M C 2019, ' Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 9, pp. 1840-1849 . https://doi.org/10.1007/s00259-019-04377-6, https://doi.org/10.1007/s00259-019-04377-6
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. Springer Verlag
PURPOSE: In-vivo quantification of tumor uptake of 89-zirconium (89Zr)-labelled monoclonal antibodies (mAbs) with PET provides a potential tool in strategies to optimize tumor targeting and therapeutic efficacy. A specific challenge for 89Zr-immuno-P